Q3 2024 13F Holders as of 9/30/2024
-
Type / Class
-
Equity / COMMON-STOCK
-
Shares outstanding
-
162M
-
Number of holders
-
217
-
Total 13F shares, excl. options
-
163M
-
Shares change
-
-8.63M
-
Total reported value, excl. options
-
$672M
-
Value change
-
-$58.3M
-
Put/Call ratio
-
0
-
Number of buys
-
101
-
Number of sells
-
-121
-
Price
-
$4.12
Significant Holders of IRONWOOD PHARMACEUTICALS INC - COMMON-STOCK (IRWD) as of Q3 2024
268 filings reported holding IRWD - IRONWOOD PHARMACEUTICALS INC - COMMON-STOCK as of Q3 2024.
IRONWOOD PHARMACEUTICALS INC - COMMON-STOCK (IRWD) has 217 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 163M shares
.
Largest 10 shareholders include BlackRock, Inc. (22.9M shares), VANGUARD GROUP INC (22M shares), Sarissa Capital Management LP (16.4M shares), Pacer Advisors, Inc. (11.3M shares), STATE STREET CORP (9.92M shares), RENAISSANCE TECHNOLOGIES LLC (8.6M shares), ARMISTICE CAPITAL, LLC (8.2M shares), LSV ASSET MANAGEMENT (5.05M shares), BRAIDWELL LP (4.44M shares), and MORGAN STANLEY (4.32M shares).
This table shows the top 217 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.